Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06072677
Other study ID # 23-1336
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 24, 2023
Est. completion date December 2027

Study information

Verified date October 2023
Source University of North Carolina, Chapel Hill
Contact Kayla Jensen, BS
Phone 919-445-6815
Email nerdlab@unc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Starting at puberty, female adolescents are nearly three-times more likely to develop internalizing disorders, like depression, while male adolescents are two-times more likely to develop externalizing disorders, like attention deficit hyperactivity disorder (ADHD). This divergence between the sexes during puberty suggests sex-specific pathways of risk and differential effects of sex hormones. The purpose of this research is to determine: 1) sex-specific neural and endocrine features of the pubertal transition that may mediate sex differences in adolescent mood disorders, and 2) the neurophysiological basis of susceptibility to hormone change during puberty.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date December 2027
Est. primary completion date December 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 11 Years to 14 Years
Eligibility Inclusion Criteria: - Between the ages of 11 and 14 - Have their own personal mobile device and capability to download the MyCap and Healthy Minds apps - Experienced a stressful life event within the last year, or endorse moderate depression (defined by a CES-DC score 16 or higher) Exclusion Criteria: - Previous experience with the Healthy Minds Program - Regular meditation practice - Current or history of manic episodes, psychotic symptoms, or current suicidal intent - Taking any form of exogenous hormones or intrauterine device (IUD) within one month of participation in the study - Taking medications that directly alter cardiovascular or neurological function

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Healthy Minds Program
The Healthy Minds Program is a 4-week mobile program to improve coping and emotion regulation skills. It includes 4 training modules corresponding to key pillars of wellbeing: awareness(focused attention/awareness of thoughts/emotions), connection (empathy, compassion, social connection), insight (clarity of identify/experience) and purpose (applying values/motivations). The Healthy Minds Program includes 2 introductory audio lessons and guided meditations, and each 1-week module includes 2 podcast lessons (5-7 minutes) with psychoeducation and practical examples, and 3 guided meditations relevant to the module topic, for a total of 10 lessons and 14 guided meditations.

Locations

Country Name City State
United States Carolina Crossing B, Suite 1 Chapel Hill North Carolina

Sponsors (2)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill Foundation of Hope, North Carolina

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary CES-DC Score Over Time The 20-item Center for Epidemiological Studies Depression Scale for Children (CES-DC) will be the primary measure of severity of depressive symptoms. Each item is rated 0 (not at all) to 3 (a lot), with items 4, 8, 12, and 16 being reversed scored. The total CES-DC score may range from 0-60. Higher scores indicate more severe depressive symptoms. Scores of 15 or greater are suggestive of significant depressive symptoms. The overall CES-DC score will be assessed at the end of each week in the study. up to Week 8
See also
  Status Clinical Trial Phase
Completed NCT00399776 - Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy N/A
Completed NCT04603053 - Determining Effectiveness of an mHealth Intervention to Provide Adolescent CBT N/A
Completed NCT01802437 - An Adaptive Treatment Strategy for Adolescent Depression Phase 1/Phase 2
Completed NCT06325605 - Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression N/A
Completed NCT02017535 - An Adaptive Treatment Strategy for Adolescent Depression-Continuation Phase 1/Phase 2
Completed NCT03154008 - Predictors of Response to Treatment for Depression N/A
Recruiting NCT04613453 - Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine Phase 2
Terminated NCT00284791 - Lamotrigine in Treatment Resistant Depression in Adolescents N/A
Completed NCT00312897 - Omega-3 Fatty Acids in Adolescent Depression Phase 2
Recruiting NCT01857518 - Depression in Adolescents. A Cerebral Structural, Diffusion, and Functional Magnetic Resonance Imaging Study N/A
Recruiting NCT01170520 - Repetitive Transcranial Stimulation (rTMS) for Resistant Depression in Adolescents Phase 1/Phase 2